Filing metadata

Accession number
0001492422-26-000091
Form type
Form 3
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Mar 03, 2026
Reporting period
Mar 02, 2026
Description
Initial ownership

Explore SEC Filings Hub

3 | SEC Filings Hub